Proteomic-Based Detection of Urine Proteins Associated with Acute Renal Allograft Rejection

Journal of the American Society of Nephrology

Volumn 15, Issue 1, 2004, Pages 219-227

  Schaub, Stefan ^a,b   Rush, David ^a,b   Wilkins, John ^a,b   Gibson, Ian W ^a   Weiler, Tracey ^a,b   Sangster, Kevin ^a,b   Nicolle, Lindsay ^a   Karpinski, Martin ^a   Jeffery, John ^a   Nickerson, Peter ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Manitoba Centre for Proteomics   (Canada)

^c Immunogenetics Laboratory   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEOMICS;

EID: 9144260705     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000101031.52826.BE     Document Type: Article

References (32)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605-612, 2000
2. Agodoa L, Eknoyan G, Ingelfinger J, Keane W, Mauer M, Mitch W, Striker G, Wilcox C: Assessment of structure and function in progressive renal disease. Kidney Int Suppl 63: S144-S150, 1997
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346: 580-590, 2002
4. Meier-Kriesche HU, Ojo AO, Hanson JA, Cibrik DM, Punch JD, Leichtman AB, Kaplan B: Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 70: 1098-1100, 2000
5. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-756, 1993
6. Wilczek HE: Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies. Transplantation 50: 790-797, 1990
7. Kolb LG, Velosa JA, Bergstralh EJ, Offord KP: Percutaneous renal allograft biopsy. A comparison of two needle types and analysis of risk factors. Transplantation 57: 1742-1746, 1994
8. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J: Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57: 208-211, 1994
9. Shapiro R, Randhawa P, Jordan ML, Scantlebury VP, Vivas C, Jain A, Corry RJ, McCauley J, Johnston J, Donaldson J, Gray EA, Dvorchik I, Hakala TR, Fung JJ, Starzl TE: An analysis of early renal transplant protocol biopsies-the high incidence of subclinical tubulitis. Am J Transplant 1: 47-50, 2001
10. Sorof JM, Vartanian RK, Olson JL, Tomlanovich SJ, Vincenti FG, Amend WJ: Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation 60: 1215-1219, 1995
11. Nicholson ML, Wheatley TJ, Doughman TM, White SA, Morgan JD, Veitch PS, Furness PN: A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int 58: 390-395, 2000
12. Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, Serur D, Mouradian J, Schwartz JE, Suthanthiran M: Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perform and granzyme B in urine. N Engl J Med 344: 947-954, 2001
13. Ding R, Li B, Muthukumar T, Dadhania D, Medeiros M, Hartono C, Serur D, Seshan SV, Sharma VK, Kapur S, Suthanthiran M: CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation 75: 1307-1312, 2003
14. Roberti I, Reisman L, Burrows L, Lieberman KV: Urine cytology and urine flow cytometry in renal transplantation-a prospective double blind study. Transplantation 59: 495-500, 1995
15. Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Dejelo C, Boehm BO, Hering BJ, Heeger PS: Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2: 857-866, 2002
16. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH: Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13: 252-259, 2002
17. Scherer A, Krause A, Walker JR, Korn A, Niese D, Raulf F: Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 75: 1323-1330, 2003
18. Eikmans M, Sijpkens YW, Baelde HJ, De Heer E, Paul LC, Bruijn JA: High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 73: 573-579, 2002
19. Stegall M, Park W, Kim D, Kremers W: Gene expression during acute allograft rejection: Novel statistical analysis of microarray data. Am J Transplant 2: 913-925, 2002
20. Chua MS, and Sarwal MM: Microarrays: New tools for transplantation research. Pediatr Nephrol 18: 319-327, 2003
21. Knepper MA: Proteomics and the kidney. J Am Soc Nephrol 13: 1398-1408, 2002
22. Hanash S: Disease proteomics. Nature 422: 226-232, 2003
23. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
24. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P: Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int in press
25. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP: Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 237: 660-665, 2003
26. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577, 2002
27. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J: Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347: 488-496, 2002
28. Sagedal S, Nordal KP, Hartmann A, Degre M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H: A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation 70: 1166-1174, 2000
29. Abecassis MM, Koffron AJ, Kaplan B, Buckingham M, Muldoon JP, Cribbins AJ, Kaufman DB, Fryer JP, Stuart J, Stuart FP: The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy? Transplantation 63: 275-279, 1997
30. Andersen CB, Ladefoged SD, Lauritsen HK, Hansen PR, Larsen S: Detection of CMV DNA and CMV antigen in renal allograft biopsies by in situ hybridisation and immunohistochemistry. Nephrol Dial Transplant 5: 1045-1050, 1990
31. Kashyap R, Shapiro R, Jordan M, Randhawa PS: The clinical significance of cytomegaloviral inclusions in the allograft kidney. Transplantation 67: 98-103, 1999
32. Karpinski M, Rush D, Jeffery J, Pochinco D, Milley D, Nickerson P: Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejection. J Am Soc Nephrol 14: 226-233, 2003